Suppr超能文献

剑突下与外侧入路治疗早期前纵隔胸腺瘤的临床分析

Clinical analysis of subxiphoid vs. lateral approaches for treating early anterior mediastinal thymoma.

作者信息

Li Bin, Niu Lijuan, Gu Chenqi, He Kaiwen, Wu Ruizhi, Pan Zhenfeng, Chen Shaomu

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Endocrinology, The First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

Front Surg. 2022 Sep 9;9:984043. doi: 10.3389/fsurg.2022.984043. eCollection 2022.

Abstract

OBJECTIVE

To investigate the clinical efficacy of the subxiphoid approach for early anterior mediastinal thymoma and evaluate its advantages over the lateral intercostal approach.

METHODS

A total of 345 patients with early anterior mediastinal thymoma were retrospectively analyzed from January 2016 to December 2020 in the First Affiliated Hospital of Soochow University. Out of these, 99 patients underwent subxiphoid video-assisted thoracoscopic thymectomy and 246 patients underwent transthoracic video-assisted thoracoscopic thymectomy. We compared the intraoperative conditions (such as operation time and intraoperative blood loss), postoperative conditions [such as postoperative pleural drainage volume, extubation time, postoperative hospital stay, and postoperative visual analogue scale (VAS) pain score], and postoperative complications (such as death, pneumonia, delayed wound healing, cardiac arrhythmia, and phrenic nerve injury) of the two groups and analyzed the clinical advantages of the subxiphoid approach for treating early anterior mediastinal thymoma.

RESULTS

There was no significant difference between the two groups in terms of general clinical features, operation time, and postoperative complications ( > 0.05).However, there was a significant difference in terms of intraoperative blood loss, postoperative pleural drainage volume, tube extubation time, postoperative hospital stay, postoperative VAS pain score, and postoperative analgesics (a significantly decreased flurbiprofen axetil amount) ( < 0.05).

CONCLUSION

Compared with the lateral intercostal thoracic approach, the subxiphoid approach had advantages in terms of intraoperative blood loss, postoperative hospital stay, tube extubation time, postoperative pleural drainage volume, postoperative VAS pain score, and analgesics dosage. It could provide a better view of the bilateral pleural cavities and more thorough thymectomy and superior cosmesis, and it proved to be a safe and feasible minimally invasive surgical method.

摘要

目的

探讨剑突下入路治疗早期前纵隔胸腺瘤的临床疗效,并评估其相对于外侧肋间入路的优势。

方法

回顾性分析2016年1月至2020年12月苏州大学附属第一医院收治的345例早期前纵隔胸腺瘤患者。其中,99例行剑突下电视辅助胸腔镜胸腺切除术,246例行经胸电视辅助胸腔镜胸腺切除术。比较两组患者的术中情况(如手术时间和术中出血量)、术后情况[如术后胸腔引流量、拔管时间、术后住院时间及术后视觉模拟评分法(VAS)疼痛评分]以及术后并发症(如死亡、肺炎、伤口愈合延迟、心律失常及膈神经损伤),并分析剑突下入路治疗早期前纵隔胸腺瘤的临床优势。

结果

两组患者的一般临床特征、手术时间及术后并发症方面差异无统计学意义(>0.05)。然而,术中出血量、术后胸腔引流量、拔管时间、术后住院时间、术后VAS疼痛评分及术后镇痛药(氟比洛芬酯用量显著减少)方面差异有统计学意义(<0.05)。

结论

与外侧肋间胸腔入路相比,剑突下入路在术中出血量、术后住院时间、拔管时间、术后胸腔引流量、术后VAS疼痛评分及镇痛药用量方面具有优势。它能提供更好的双侧胸腔视野,胸腺切除更彻底,美容效果更佳,是一种安全可行的微创手术方法。

相似文献

10
Thoracoscopic Thymectomy Using a Subxiphoid Approach for Anterior Mediastinal Tumors.剑突下入路胸腔镜胸腺切除术治疗前纵隔肿瘤
Ann Thorac Cardiovasc Surg. 2018 Apr 20;24(2):65-72. doi: 10.5761/atcs.oa.17-00128. Epub 2018 Jan 9.

本文引用的文献

4
Subxiphoid and subcostal thoracoscopic surgical approach for thymectomy.剑突下和肋缘下胸腔镜胸腺切除术手术入路
Surg Endosc. 2021 Sep;35(9):5239-5246. doi: 10.1007/s00464-020-08022-4. Epub 2020 Sep 24.
6
Subxiphoid approach for robotic single-site-assisted thymectomy.剑突下入路机器人辅助单部位胸腺切除术。
Eur J Cardiothorac Surg. 2020 Aug 1;58(Suppl_1):i34-i38. doi: 10.1093/ejcts/ezaa036.
9
Technique for Myasthenia Gravis: Subxiphoid Approach.重症肌无力手术技巧:剑突下入路
Thorac Surg Clin. 2019 May;29(2):195-202. doi: 10.1016/j.thorsurg.2018.12.010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验